High-Risk Securities

Business

Beyond the Giants: Hongli Group and Two Penny Stocks Drawing Investor Scrutiny Amid Market Calm

While major indices tread water ahead of key earnings, a segment of the market continues to buzz with activity. We examine three micro-cap companies—Hongli Group, Royalty Management, and CreateAI—whose financial profiles and strategic moves are capturing attention from investors willing to navigate the high-risk, high-reward penny stock arena.

Jan 30, 2026

Business

Mizuho Upgrades Applied Materials to Outperform, Citing Strong Global Chip Equipment Demand

Mizuho Securities raised its rating on Applied Materials (AMAT) to Outperform, with a $370 price target, forecasting accelerated growth in global wafer fab equipment spending driven by major chipmakers' capital expenditure plans.

Jan 30, 2026

Business

Blue Owl Capital Navigates Legal Storm: Liquidity Lawsuits Clash with Analyst Confidence

Blue Owl Capital faces a wave of securities class actions alleging disclosure failures around liquidity and redemptions, casting a shadow over its robust alternative asset management platform. As legal pressures mount, the market weighs solid analyst backing against growing governance concerns, setting the stage for a pivotal earnings report.

Jan 30, 2026

Business

Southside Bancshares Navigates Higher Rates, Posts Q4 Profit Rebound Amid Strategic Portfolio Shift

Southside Bancshares (SBSI) reported a significant rebound in fourth-quarter earnings, driven by strategic repositioning of its securities portfolio and lower funding costs. While loan growth remained modest, executives outlined a cautious outlook for near-term margin improvement and detailed plans for technology investments and selective M&A in competitive Texas markets.

Jan 30, 2026

Business

BofA Doubles Down on Hesai Group, Boosts Price Target on Lidar Leadership and Regulatory Tailwinds

Bank of America Securities has reaffirmed its Buy rating on Hesai Group (HSAI), raising its price target to $32, citing the lidar maker's technological milestones, strategic partnership with NVIDIA, and favorable regulatory developments for autonomous driving.

Jan 30, 2026

Business

Truist Bullish on Amer Sports, Forecasts EPS Above $2.50 by 2030 on Strong Growth Strategy

Truist Securities has raised its price target for Amer Sports (NYSE: AS), citing the company's clear long-term roadmap and 'durable growth levers' across its portfolio of iconic sports brands. The firm sees a realistic path to earnings per share exceeding $2.50 by fiscal 2030.

Jan 30, 2026

Business

Nuvation Bio's Ibtrozi Gains Favor on Strong Launch, Truist Raises Target

Truist Securities has increased its price target for Nuvation Bio, highlighting the promising early commercial traction of its oncology drug Ibtrozi, which is outpacing competitors in the ROS1 inhibitor space.

Jan 30, 2026

Business

Mizuho Lifts SanDisk Target to $600, Citing NAND Supply Crunch and AI-Driven Demand Surge

Mizuho Securities dramatically raised its price target on SanDisk, forecasting a severe NAND flash memory shortage driven by explosive AI server demand and constrained production capacity through 2027.

Jan 30, 2026

Business

Meta Stock Surges Over 10% as Analysts Boost Price Target, Citing AI Leadership

Shares of Meta Platforms soared Thursday, fueled by a significant price target upgrade from BofA Securities. The rally comes despite the company reporting a slight dip in full-year profit, as investors focus on strong revenue growth and the company's positioning in the artificial intelligence race.

Jan 30, 2026

Business

IonQ's Quantum Ambitions Face Market Reality Check: Is This Dip Worth Buying?

Despite a star-studded client list and explosive revenue growth, IonQ's towering valuation and the nascent state of quantum computing signal significant risk for investors eyeing the recent sell-off.

Feb 2, 2026

Business

Erasca Soars 460% in a Year: A Biotech Bet Riding on Hope and High Stakes

Clinical-stage biotech Erasca (ERAS) has seen its stock skyrocket over the past 12 months, hitting a multi-year high. While technical momentum is strong, the company remains pre-revenue, with its fate tied to future drug approvals, presenting a classic high-risk, high-reward scenario for investors.

Feb 2, 2026

Business

Beyond the Blue Chips: Three Penny Stocks Drawing Investor Scrutiny Amid Market Optimism

As major indices climb, a segment of investors is turning their gaze to high-risk, high-reward penny stocks. We examine three companies—FingerMotion, PodcastOne, and MOGU—that are on the radar, weighing their potential against significant financial challenges.

Feb 2, 2026

Business

CapWealth Makes Bold Bet on Lumen Technologies with $10 Million Share Purchase

Investment firm CapWealth Advisors has significantly increased its stake in telecom provider Lumen Technologies, signaling confidence amid the company's strategic pivot towards enterprise and AI infrastructure.

Feb 2, 2026

Business

Chemical Giants Dow and LyondellBasell: High-Yield Turnaround Bets for 2026

After a punishing multi-year slump, materials stocks are showing signs of life in 2026. Dow and LyondellBasell, offering yields of 5% and 10.9% respectively, present a high-risk, high-reward proposition for income investors betting on a sector recovery.

Feb 2, 2026

Business

Warsh's Fed Balance Sheet Ambition Faces Daunting Market Realities

Nominee Kevin Warsh's desire to aggressively shrink the Federal Reserve's multi-trillion dollar holdings collides with a financial system now structurally dependent on ample liquidity, making rapid contraction a high-risk endeavor, analysts say.

Feb 2, 2026

Business

Tyler Technologies: A Profitable Contender in a Speculative Market

While many chase high-risk, loss-making stories, Tyler Technologies (TYL) stands out with consistent profitability and growth. We examine the key metrics and management alignment that make this software provider a stock worth watching.

Feb 2, 2026

Business

Mizuho Bullish on Erasca, Initiates Coverage with $16 Target Amid RAS Inhibitor Progress

Erasca (ERAS) gains significant analyst momentum as Mizuho initiates coverage with an 'Outperform' rating and a $16 price target, citing confidence in its 2026 proof-of-concept milestones for RAS-targeted cancer therapies.

Feb 2, 2026

Business

Beneath the Radar: Three Asian Small-Caps Under $200M Drawing Investor Scrutiny

Amidst shifting economic currents in Asia, a class of smaller companies—often overlooked as 'penny stocks'—is attracting attention for their distinct financial profiles and niche market positions. We analyze three such firms with market capitalizations below US$200 million.

Feb 2, 2026

Business

From Nvidia to Quantum: The $20 Million Investor's Blueprint for Spotting the Next Tech Megatrend

A software engineer who turned an early bet on Nvidia into a $20 million fortune and early retirement is now pointing to quantum computing as the frontier with similar explosive potential. His journey underscores the high-risk, high-reward nature of thematic investing.

Feb 2, 2026

Business

Skellerup Holdings Delivers Steady Growth Amid Market Volatility, Insider Confidence Signals Stability

While high-risk tech stocks dominate headlines, Skellerup Holdings (NZSE:SKL) demonstrates how consistent EPS growth, disciplined leadership compensation, and strong insider alignment can build a resilient investment case in uncertain times.

Jan 30, 2026